Intismeran plus pembrolizumab improves recurrence free survival in resected high risk melanoma

ESMO 2026: Advances in NMIBC and MIBC

UV1 vaccine combination shows no significant PFS improvement in BRCA wild type recurrent ovarian cancer

Camupepimut shows early disease free survival signal in resected KRAS mutated pancreatic cancer

Sacituzumab govitecan combination shows promising activity in first line metastatic urothelial cancer

UEG 2026: Improving early detection of colorectal cancer

Tarlatamab's role in SCLC

WCLC 2026: Lung cancer research highlights

Safeguarding the right to work for people with advanced breast cancer (ABC) and their caregivers: A global snapshot of legislati

Equitable precision oncology in Africa

Harnessing AI and data to predict, personalise and transform cancer care

Izalontamab brenitecan shows promising activity in previously treated EGFR mutated NSCLC